IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 31 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $3,444,000 | -85.7% | 3,219,000 | -85.3% | 0.00% | -88.2% |
Q1 2019 | $24,023,000 | +401.9% | 21,846,000 | +326.8% | 0.02% | +325.0% |
Q4 2018 | $4,786,000 | +237.0% | 5,119,000 | +367.9% | 0.00% | +300.0% |
Q3 2018 | $1,420,000 | +296.6% | 1,094,000 | +305.2% | 0.00% | – |
Q2 2018 | $358,000 | -38.6% | 270,000 | -46.4% | 0.00% | – |
Q4 2017 | $583,000 | +53.8% | 504,000 | +58.0% | 0.00% | – |
Q3 2017 | $379,000 | 0.0% | 319,000 | +4.6% | 0.00% | – |
Q1 2017 | $379,000 | +46.3% | 305,000 | +40.6% | 0.00% | – |
Q3 2016 | $259,000 | – | 217,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opti Capital Management, LP | 11,901 | $11,946,000 | 2.07% |
Context Capital Management, LLC | 1,000,000 | $997,000 | 0.56% |
WOLVERINE ASSET MANAGEMENT LLC | 33,392,000 | $33,442,000 | 0.42% |
SSI INVESTMENT MANAGEMENT LLC | 3,000,000 | $2,991,000 | 0.22% |
CSS LLC/IL | 2,876,000 | $2,883,000 | 0.18% |
PALISADE CAPITAL MANAGEMENT, LP | 5,000,000 | $5,016,000 | 0.15% |
HBK INVESTMENTS L P | 10,116,000 | $10,186,000 | 0.13% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 1,817,000 | $1,835,000 | 0.11% |
LINDEN ADVISORS LP | 6,269,000 | $6,290,000 | 0.08% |
LAZARD ASSET MANAGEMENT LLC | 15,000,000 | $15,028,000 | 0.02% |